Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects?

Biological Psychiatry

Volumn 48, Issue 1, 2000, Pages 1-8

  Moore, Gregory J ^a   Bebchuk, Joseph M ^a   Hasanat, Khondakar ^a   Chen, Guang ^a   Seraji Bozorgzad, Navid ^a   Wilds, Ian B ^a   Faulk, Michael W ^a   Koch, Susanne ^a   Glitz, Debra A ^a   Jolkovsky, Libby ^a   Manji, Husseini K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bcl 2; Bipolar mood disorder; Lithium; Magnetic resonance spectroscopy; N acetyl aspartate; Neuroprotection

Indexed keywords

LITHIUM; MARKER; N ACETYLASPARTIC ACID; NEUROTROPHIC FACTOR; PROTEIN BCL 2;

ADULT; ARTICLE; BRAIN; BRAIN NERVE CELL; BRAIN REGION; CELL FUNCTION; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; FRONTAL LOBE; HUMAN; HUMAN EXPERIMENT; MALE; MANIC DEPRESSIVE PSYCHOSIS; NEUROPROTECTION; NORMAL HUMAN; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE; VOLUNTEER;

ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; BIPOLAR DISORDER; BRAIN; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION REGULATION; GENES, BCL-2; HUMANS; LITHIUM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PROSPECTIVE STUDIES;

EID: 18744435263     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00252-3     Document Type: Article

References (60)

1. Adams J.M., Cory S. The Bcl-2 protein family Arbiters of cell survival . Science. 281:1998;1322-1326.
2. Baldessarini R.J., Tondo L., Hennen J. Effects of lithium treatment and its discontinuation in bipolar manic-depressive disorders. J Clin Psychiatry Suppl. 60:1999;77-84.
3. Barker P., Breiter S., Soher B., Chatham J., Forder J., Samphilipo M., et al. Quantitative proton spectroscopy of canine brain In vivo and in vitro correlations . Magn Reson Med. 32:1994;157-163.
4. Barker P.B., Soher B.J., Blackband S.J., Chatham J.C., Mathews V.P., Ryan R.N. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed. 6:1993;89-94.
5. Birken D.L., Oldendorf W.H. N-acetyl-L-aspartic acid A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain . Neurosci Biobehav Rev. 13:1989;23-31.
6. Brooks W.M., Friedman S.D., Stidley C.A. Reproducibility of 1H-MRS in vivo. Magn Reson Med. 41:1999;193-197.
7. Bruckheimer E.M., Cho S.H., Sarkiss M., Herrmann J., McDonnell T.J. The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol. 62:1998;75-105.
8. Cendes F., Andermann F., Dubeau F., Mathews P.M., Arnold D.L. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology. 49:1997;1525-1533.
9. Chen D.F., Schneider G.E., Martinou J.C., Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature. 385:1997;434-439.
10. Chen G., Zeng W.Z., Jiang L., Yuan P.X., Zhao J., Manji H.K. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 72:1999;879-882.
11. Chen R.W., Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem. 274:1999;6039-6042.
12. Christiansen P., Henriksen O., Stubgaard M., Gideon P., Larsson H. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging. 11:1993;107-118.
13. Davie C.A., Hawkins C.P., Barker G.J., Brennan A., Tofts P.S., Miller D.H., et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
14. deBeer R., van den Boogaart A., van Ormondt D., Pijnappel W.W., den Hollander J.A., Marien A.J., et al. Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed. 5:1992;171-178.
15. De Stefano N., Mathews P.M., Arnold D.L. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med. 34:1995;721-727.
16. De Stefano N., Matthews P.M., Ford B., Genge A., Karpati G., Arnold D.L. Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology. 45:1995;1193-1198.
17. Drevets W.C., Price J.L., Simpson J.R. Jr, Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
18. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;597-606.
19. Ellis C.M., Lemmens G., Williams S.C., Simmons A., Dawson J., Leigh P.N., et al. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease A proton magnetic resonance spectroscopy study . Neurology. 49:1997;438-444.
20. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes Initial applications to human brain in vivo . Magn Reson Med. 9:1989;79-93.
21. Frahm J., Merboldt K.D., Hanicke W. Localized proton spectroscopy using stimulated echoes. J Magn Reson. 72:1987;502-508.
22. Frahm J., Michaelis T., Merboldt K.D., Bruhn H., Gyngell M.L., Hanicke W. Improvements in localized 1H NMR spectroscopy of human brain Water suppression, short echo times and 1 ml resolution . J Magn Reson. 90:1990;464-473.
23. Goodwin F.K., Jamison K.R. Manic-Depressive Illness. 1990;Oxford University Press, New York.
24. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
25. Hennig J., Pfister H., Ernst T., Ott D. Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed. 5:1992;193-199.
26. 1H spectroscopic imaging of human brain at 4.IT using image segmentation. Magn Reson Med. 36:1996;21-29.
27. Holshouser B.A., Komu M., Moller H.E., Zijlmans J., Kolem H., Hinshaw D.B. Jr. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease A multicenter pilot study . Magn Reson Med. 33:1995;589-594.
28. 1H magnetic resonance spectroscopic imaging. Ann Neurol. 40:1996;236-239.
29. Jope R.S. Anti-bipolar therapy Mechanism of action of lithium . Mol Psychiatry. 4:1999;117-128.
30. Kalra S., Cashman N.R., Genge A., Arnold D.L. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport. 9:1998;1757-1761.
31. Ketter TA, George MS, Kimbrell TA, Willis MW, Benson BE, Post RM (1997): Neuroanatomical models and brain imaging studies in bipolar disorder: Biological models and their Clinical Application. In: Joffe RT, Young LT, editors. Bipolar Disorder: Biological Models and Their Clinical Application. New York: Marcel Dekker, 179-218.
32. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med. 14:1990;26-30.
33. Koller K.J., Zaczek R., Coyle J.T. N-acetyl-aspartyl-glutamate Regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method . J Neurochem. 43:1984;1136-1142.
34. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2 Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis . Science. 277:1997;559-562.
35. Kreis R, Ernst T, Ross B (1993): Absolute quantitation of water and metabolites in the human brain. II metabolite concentrations. J Magn Reson B102:9-19.
36. Lawrence M.S., Ho D.Y., Sun G.H., Steinberg G.K., Sapolsky R.M. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci. 16:1996;486-496.
37. Manji H.K., Moore G.J., Chen G. Lithium at 50 Have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry. 46:1999;929-940.
38. Manji H.K., Potter W.Z., Lenox R.H. Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry. 52:1995;531-543.
39. Merry D.E., Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu Rev Neurosci. 20:1997;245-267.
40. Michaelis T., Merboldt K.D., Bruhn H., Hanicke W., Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo Quantification of localized proton MR spectra . Radiology. 187:1993;219-227.
41. Moore GJ, Seraji-Bozorgzad N, Wilds IB, Manji HK (in press): Assesment of MRS voxel placement reliability using a simple semi-automated voxel segmentation approach. Med Phys.
42. Narayana P.A., Fotedar L.K., Jackson E.F., Bohaw I.D., Butler I.J., Wolinsky J.S. Regional in vivo proton magnetic resonance spectroscopy of brain. J Magn Reson. 83:1989;44-52.
43. Nonaka S., Chuang D.M. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport. 9:1998;2081-2084.
44. Nonaka S., Hough C.J., Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A. 95:1998;2642-2647.
45. Nonaka S., Katsube N., Chuang D.M. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther. 286:1998;539-547.
46. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
47. Pavlakis S.G., Lu D., Frank Y., Wiznia A., Eidelberg D., Barnett T., et al. Brain lactate and N-acetylaspartate in pediatric AIDS encephalopathy. AJNR Am J Neuroradiol. 19:1998;383-385.
48. Rajkowska G. Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann N Y Acad Sci. 836:1997;253-268.
49. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 45:1999;1085-1098.
50. Reifman A., Wyatt R.J. Lithium A brake in the rising cost of mental illness . Arch Gen Psychiatry. 37:1980;385-388.
51. Salvan A.M., Vion-Dury J., Confort-Gouny S., Nicoli F., Lamoureux S., Cozzone P.J. Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy Identification of evolving metabolic patterns in relation to dementia and therapy . AIDS Res Hum Retroviruses. 13:1997;1055-1066.
52. Smith M.A., Makino S., Altemus M., Michelson D., Hong S.K., Kvetnansky R., et al. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc Natl Acad Sci U S A. 92:1995;8788-8792.
53. Soares J.C., Mann J.J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry. 41:1997;86-106.
54. Soher B.J., Hurd R.E., Sailasuta N., Barker P.B. Quantitation of automated single-voxel proton MRS using cerebral water at an internal reference. Magn Reson Med. 36:1996;335-339.
55. Takanashi J., Sugita K., Ishii M., Aoyagi M., Niimi H. Longitudinal MR imaging and proton MR spectroscopy in herpes simplex encephalitis. J Neurol Sci. 149:1997;99-102.
56. 1. A scheme for analysis of in vivo metabolites. J Magn Reson. 55:1983;357-371.
57. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 46:1995;531-540.
58. van den Boogaart A., Ala-Korpela M., Jokisaari J., Griffiths J.R. Time and frequency domain analysis of NMR data compared an application to 1D 1H spectra of lipoproteins . Magn Reson Med. 31:1994;347-358.
59. Vion-Dury J., Nicoli F., Salvan A.M., Confort-Gouny S., Dhiver C., Cozzone P.J. Reversal of brain metabolic alterations with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet. 345:1995;60-61.
60. Yang L., Matthews R.T., Schulz J.B., Klockgether T., Liao A.W., Martinou J.C., et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J Neurosci. 18:1998;8145-8152.